{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:48:24Z","timestamp":1792784904546,"version":"4.5.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T00:00:00Z","timestamp":1776470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T00:00:00Z","timestamp":1776470400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National Science and Technology Council (NSTC), Taiwan","id":[{"id":"https:\/\/ror.org\/02kv4zf79","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gene Ther"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1038\/s41434-026-00612-6","type":"journal-article","created":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T09:19:00Z","timestamp":1776503940000},"page":"532-540","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Beneficial bystander-enhanced cryptic splice rescue of cardiac-type Fabry GLA IVS4+919G&gt;A by adenine base editing in patient fibroblasts"],"prefix":"10.1038","volume":"33","author":[{"given":"Hua-Chuan","family":"Chao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Ying","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Ting","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-Ru","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching-Tzu","family":"Yen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Ying","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng-Kai","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yen-Fu","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yung-Hsiu","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3962-1739","authenticated-orcid":false,"given":"Dau-Ming","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,18]]},"reference":[{"key":"612_CR1","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1001\/jama.281.3.249","volume":"281","author":"PJ Meikle","year":"1999","unstructured":"Meikle PJ, Hopwood JJ, Clague AE, Carey WF. Prevalence of lysosomal storage disorders. JAMA. 1999;281:249\u201354.","journal-title":"JAMA"},{"key":"612_CR2","first-page":"317","volume":"31","author":"RJ Desnick","year":"2001","unstructured":"Desnick RJ, Wasserstein MP. Fabry disease: clinical features and recent advances in enzyme replacement therapy. Adv Nephrol Necker Hosp. 2001;31:317\u201339.","journal-title":"Adv Nephrol Necker Hosp"},{"key":"612_CR3","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.1016\/j.jpeds.2004.01.051","volume":"144","author":"RJ Desnick","year":"2004","unstructured":"Desnick RJ, Brady RO. Fabry disease in childhood. J Pediatr. 2004;144:S20\u20136.","journal-title":"J Pediatr"},{"key":"612_CR4","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1136\/hrt.2003.031666","volume":"90","author":"GS Bhatia","year":"2004","unstructured":"Bhatia GS, Leahy JF, Connolly DL, Davis RC. Severe left ventricular hypertrophy in Anderson-Fabry disease. Heart. 2004;90:1136.","journal-title":"Heart"},{"key":"612_CR5","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1016\/S0140-6736(08)61589-5","volume":"372","author":"YA Zarate","year":"2008","unstructured":"Zarate YA, Hopkin RJ. Fabry\u2019s disease. Lancet. 2008;372:1427\u201335.","journal-title":"Lancet"},{"key":"612_CR6","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.ijcard.2009.08.002","volume":"141","author":"F Weidemann","year":"2010","unstructured":"Weidemann F, Linhart A, Monserrat L, Strotmann J. Cardiac challenges in patients with Fabry disease. Int J Cardiol. 2010;141:3\u201310.","journal-title":"Int J Cardiol"},{"key":"612_CR7","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1056\/NEJM199508033330504","volume":"333","author":"S Nakao","year":"1995","unstructured":"Nakao S, Takenaka T, Maeda M, Kodama C, Tanaka A, Tahara M, et al. An atypical variant of Fabry\u2019s disease in men with left ventricular hypertrophy. N Engl J Med. 1995;333:288\u201393.","journal-title":"N Engl J Med"},{"key":"612_CR8","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1161\/01.CIR.0000012626.81324.38","volume":"105","author":"B Sachdev","year":"2002","unstructured":"Sachdev B, Takenaka T, Teraguchi H, Tei C, Lee P, McKenna WJ, et al. Prevalence of Anderson-Fabry disease in male patients with late onset hypertrophic cardiomyopathy. Circulation. 2002;105:1407\u201311.","journal-title":"Circulation"},{"key":"612_CR9","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1097\/01.ASN.0000124671.61963.1E","volume":"15","author":"P Kotanko","year":"2004","unstructured":"Kotanko P, Kramar R, Devrnja D, Paschke E, Voigtlander T, Auinger M, et al. Results of a nationwide screening for Anderson-Fabry disease among dialysis patients. J Am Soc Nephrol. 2004;15:1323\u20139.","journal-title":"J Am Soc Nephrol"},{"key":"612_CR10","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1111\/j.1468-1331.2005.01016.x","volume":"12","author":"N Tanaka","year":"2005","unstructured":"Tanaka N, Utsumi K, Seta T, Usuda K, Komaba Y, Katsumata T, et al. Recurrent strokes in a young adult patient with Fabry\u2019s disease. Eur J Neurol. 2005;12:486\u20137.","journal-title":"Eur J Neurol"},{"key":"612_CR11","doi-asserted-by":"publisher","first-page":"2399","DOI":"10.1016\/j.jacc.2007.06.062","volume":"50","author":"L Monserrat","year":"2007","unstructured":"Monserrat L, Gimeno-Blanes JR, Marin F, Hermida-Prieto M, Garcia-Honrubia A, Perez I, et al. Prevalence of Fabry disease in a cohort of 508 unrelated patients with hypertrophic cardiomyopathy. J Am Coll Cardiol. 2007;50:2399\u2013403.","journal-title":"J Am Coll Cardiol"},{"key":"612_CR12","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1136\/heart.89.8.819","volume":"89","author":"SF Nagueh","year":"2003","unstructured":"Nagueh SF. Fabry disease. Heart. 2003;89:819\u201320.","journal-title":"Heart"},{"key":"612_CR13","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1161\/CIRCGENETICS.109.862920","volume":"2","author":"HY Lin","year":"2009","unstructured":"Lin HY, Chong KW, Hsu JH, Yu HC, Shih CC, Huang CH, et al. High incidence of the cardiac variant of Fabry disease revealed by newborn screening in the Taiwan Chinese population. Circ Cardiovasc Genet. 2009;2:450\u20136.","journal-title":"Circ Cardiovasc Genet"},{"key":"612_CR14","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1086\/339431","volume":"70","author":"S Ishii","year":"2002","unstructured":"Ishii S, Nakao S, Minamikawa-Tachino R, Desnick RJ, Fan JQ. Alternative splicing in the alpha-galactosidase A gene: increased exon inclusion results in the Fabry cardiac phenotype. Am J Hum Genet. 2002;70:994\u20131002.","journal-title":"Am J Hum Genet"},{"key":"612_CR15","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1056\/NEJM200107053450102","volume":"345","author":"CM Eng","year":"2001","unstructured":"Eng CM, Guffon N, Wilcox WR, Germain DP, Lee P, Waldek S, et al. Safety and efficacy of recombinant human alpha-galactosidase A replacement therapy in Fabry\u2019s disease. N Engl J Med. 2001;345:9\u201316.","journal-title":"N Engl J Med"},{"key":"612_CR16","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1136\/jmedgenet-2017-104863","volume":"55","author":"M Arends","year":"2018","unstructured":"Arends M, Biegstraaten M, Wanner C, Sirrs S, Mehta A, Elliott PM, et al. Agalsidase alfa versus agalsidase beta for the treatment of Fabry disease: an international cohort study. J Med Genet. 2018;55:351\u20138.","journal-title":"J Med Genet"},{"key":"612_CR17","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1038\/nature17946","volume":"533","author":"AC Komor","year":"2016","unstructured":"Komor AC, Kim YB, Packer MS, Zuris JA, Liu DR. Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage. Nature. 2016;533:420\u20134.","journal-title":"Nature"},{"key":"612_CR18","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1126\/science.aav9973","volume":"364","author":"E Zuo","year":"2019","unstructured":"Zuo E, Sun Y, Wei W, Yuan T, Ying W, Sun H, et al. Cytosine base editor generates substantial off-target single-nucleotide variants in mouse embryos. Science. 2019;364:289\u201392.","journal-title":"Science"},{"key":"612_CR19","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1038\/s41587-020-0414-6","volume":"38","author":"JL Doman","year":"2020","unstructured":"Doman JL, Raguram A, Newby GA, Liu DR. Evaluation and minimization of Cas9-independent off-target DNA editing by cytosine base editors. Nat Biotechnol. 2020;38:620\u20138.","journal-title":"Nat Biotechnol"},{"key":"612_CR20","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s42003-019-0745-3","volume":"3","author":"HK Lee","year":"2020","unstructured":"Lee HK, Smith HE, Liu C, Willi M, Hennighausen L. Cytosine base editor 4 but not adenine base editor generates off-target mutations in mouse embryos. Commun Biol. 2020;3:19.","journal-title":"Commun Biol"},{"key":"612_CR21","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1002\/humu.23819","volume":"40","author":"J Tang","year":"2019","unstructured":"Tang J, Lee T, Sun T. Single-nucleotide editing: From principle, optimization to application. Hum Mutat. 2019;40:2171\u201383.","journal-title":"Hum Mutat"},{"key":"612_CR22","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/nature24644","volume":"551","author":"NM Gaudelli","year":"2017","unstructured":"Gaudelli NM, Komor AC, Rees HA, Packer MS, Badran AH, Bryson DI, et al. Programmable base editing of A*T to G*C in genomic DNA without DNA cleavage. Nature. 2017;551:464\u201371.","journal-title":"Nature"},{"key":"612_CR23","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1038\/nbt.4172","volume":"36","author":"LW Koblan","year":"2018","unstructured":"Koblan LW, Doman JL, Wilson C, Levy JM, Tay T, Newby GA, et al. Improving cytidine and adenine base editors by expression optimization and ancestral reconstruction. Nat Biotechnol. 2018;36:843\u20136.","journal-title":"Nat Biotechnol"},{"key":"612_CR24","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1038\/s10038-020-0745-7","volume":"65","author":"KH Liang","year":"2020","unstructured":"Liang KH, Lu YH, Niu CW, Chang SK, Chen YR, Cheng CY, et al. The Fabry disease-causing mutation, GLA IVS4+919G>A, originated in Mainland China more than 800 years ago. J Hum Genet. 2020;65:619\u201325.","journal-title":"J Hum Genet"},{"key":"612_CR25","doi-asserted-by":"publisher","first-page":"e0239675","DOI":"10.1371\/journal.pone.0239675","volume":"15","author":"C Sadasivan","year":"2020","unstructured":"Sadasivan C, Chow JTY, Sheng B, Chan DKH, Fan Y, Choi PCL, et al. Screening for Fabry Disease in patients with unexplained left ventricular hypertrophy. PLoS One. 2020;15:e0239675.","journal-title":"PLoS One"},{"key":"612_CR26","doi-asserted-by":"publisher","first-page":"2554","DOI":"10.1016\/j.jacc.2016.09.943","volume":"68","author":"TR Hsu","year":"2016","unstructured":"Hsu TR, Hung SC, Chang FP, Yu WC, Sung SH, Hsu CL, et al. Later Onset Fabry Disease, Cardiac Damage Progress in Silence: Experience With a Highly Prevalent Mutation. J Am Coll Cardiol. 2016;68:2554\u201363.","journal-title":"J Am Coll Cardiol"},{"key":"612_CR27","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/1532-429X-15-92","volume":"15","author":"JC Moon","year":"2013","unstructured":"Moon JC, Messroghli DR, Kellman P, Piechnik SK, Robson MD, Ugander M, et al. Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement. J Cardiovasc Magn Reson. 2013;15:92.","journal-title":"J Cardiovasc Magn Reson"},{"key":"612_CR28","first-page":"544","volume":"40","author":"CL Hung","year":"2024","unstructured":"Hung CL, Wu YW, Kuo L, Sung KT, Lin HH, Chang WT, et al. 2024 update of the TSOC expert consensus of Fabry disease. Acta Cardiol Sin. 2024;40:544\u201368.","journal-title":"Acta Cardiol Sin"},{"key":"612_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-26789-5","volume":"12","author":"Q Wang","year":"2021","unstructured":"Wang Q, Yang J, Zhong Z, Vanegas JA, Gao X, Kolomeisky AB. A general theoretical framework to design base editors with reduced bystander effects. Nat Commun. 2021;12:6529.","journal-title":"Nat Commun"},{"key":"612_CR30","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adt9695","volume":"11","author":"T Awaya","year":"2025","unstructured":"Awaya T, Ajiro M, Kobayashi H, Sawada T, Gotanda K, Noji T, et al. Invention of an oral medication for cardiac Fabry disease caused by RNA mis-splicing. Sci Adv. 2025;11:eadt9695.","journal-title":"Sci Adv"}],"container-title":["Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41434-026-00612-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41434-026-00612-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41434-026-00612-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T13:58:36Z","timestamp":1789653516000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41434-026-00612-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,18]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["612"],"URL":"https:\/\/doi.org\/10.1038\/s41434-026-00612-6","relation":{},"ISSN":["0969-7128","1476-5462"],"issn-type":[{"value":"0969-7128","type":"print"},{"value":"1476-5462","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,18]]},"assertion":[{"value":"30 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A patent related to this work has been filed and granted with the Taiwan Intellectual Property Office (R.O.C. Patent I838812) by Taipei Veterans General Hospital. Dau-Ming Niu, Yu-Ying Lu, Yun-Ru Chen, and Ching-Tzu Yen are listed as inventors. The other authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"Patient fibroblasts (IVS4+919G>A) were obtained at Taipei Veterans General Hospital under IRB approval (2020-12-007CC). Written informed consent was obtained in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Ethics"}}]}}